Anthrax Vaccine Market
Anthrax Vaccine Market Forecasts to 2030 - Global Analysis By Vaccine Type (Live Attenuated Vaccine, Cell Free PA Vaccine and Other Vaccine Types), Type, Disease Indication, Age Group, Application, End User and By Geography
According to Stratistics MRC, the Global Anthrax Vaccine Market is accounted for $12.9 billion in 2023 and is expected to reach $20.2 billion by 2030 growing at a CAGR of 6.5% during the forecast period. The Anthrax vaccine is a preventive measure designed to protect individuals from anthrax, a potentially serious bacterial infection caused by the bacterium Bacillus anthracis. Anthrax can affect humans and other animals, and it can occur in three forms: cutaneous (skin), inhalation, and gastrointestinal. The vaccine is primarily developed to safeguard military personnel, laboratory workers, and individuals at high risk of exposure to anthrax spores. The vaccine stimulates the immune system to produce antibodies against the protective antigen component of the bacillus anthracis bacterium.
According to an article published in the Veterinary World Journal in April 2021, the prevalence of anthrax globally was 28% from 2452 samples through the fixed effects model. The random effects model's continent-by-subgroup study showed that the pooled prevalence of anthrax was highest in Africa (29%) and lowest in North America (21%).
Market Dynamics:
Driver:
Increase in prevalence of anthrax
The market has witnessed a notable surge in prevalence, reflecting a growing concern for anthrax-related risks. This upswing has heightened demand for effective vaccines, prompting advancements in research and development. The increasing prevalence of anthrax underscores the imperative for comprehensive vaccination strategies, driving market growth and innovation. However, increasing awareness and education about anthrax vaccines is paramount for public health is the factor propelling the growth of the market.
Restraint:
Side effects and safety concerns
The anthrax vaccine, while effective in preventing anthrax, may cause mild to moderate side effects such as pain, swelling, or redness at the injection site. Some individuals may experience fever, muscle aches, or fatigue. Severe allergic reactions are rare but possible. Safety concerns include reports of adverse events, though the overall risk-benefit profile supports its use for those at high risk of anthrax exposure. These are the factors hampering the growth of the market.
Opportunity:
Technological advancements
The market has witnessed significant technological advancements, with the development of next-generation vaccines incorporating innovative delivery systems and adjuvant to enhance efficacy and safety. Advanced biotechnological methods, such as recombinant DNA technology, have been employed to produce more effective and scalable vaccines. Additionally, advancements in formulation and storage technologies contribute to improved stability and ease of distribution.
Threat:
High manufacturing costs
The complex production process, stringent quality control measures, and the need for specialized facilities contribute to elevated expenses. These high manufacturing costs not only impact the affordability of the vaccine but also pose challenges for market accessibility and widespread distribution, limiting its availability to a broader population. Addressing these cost-related barriers is crucial for enhancing the affordability and accessibility of anthrax vaccines. These are the factors hindering the growth of the market.
Covid-19 Impact:
The COVID-19 pandemic has indirectly impacted the market, with shifts in healthcare priorities and resources. Attention and funding diverted to combat the pandemic may have slowed Anthrax vaccine research and development. Additionally, disruptions in supply chains and healthcare systems could affect manufacturing and distribution. However, the heightened focus on public health and biodefense may underscore the importance of anthrax vaccines, potentially leading to increased awareness and investment in the post-pandemic landscape.
The live attenuated vaccine segment is expected to be the largest during the forecast period
The live attenuated vaccine segment is expected to be the largest during the forecast period. Live attenuated vaccines for anthrax have gained prominence in the market, offering a promising approach to immunization. Leveraging weakened forms of the anthrax bacterium, these vaccines stimulate a robust immune response without causing the disease. The market for anthrax vaccines is witnessing a notable surge in demand for live attenuated options due to their efficacy in conferring long-lasting immunity.
The pharmacies segment is expected to have the highest CAGR during the forecast period
The pharmacies segment is expected to have the highest CAGR during the forecast period. These establishments serve as distribution points for anthrax vaccines, ensuring that individuals and healthcare providers can easily procure the necessary doses. Pharmacies also contribute to public health by offering information and guidance on vaccination schedules, potential side effects, and proper administration. Their involvement in the Anthrax Vaccine market enhances overall vaccine availability and promotes community protection against this serious infectious disease.
Region with largest share:
North America is projected to hold the largest market share during the forecast period. The region's robust healthcare infrastructure and rising awareness regarding bioterrorism threats contribute to market expansion. Key market players are actively engaged in research and development to enhance vaccine efficacy, fostering market competitiveness. Additionally, strategic collaborations between pharmaceutical companies and government bodies further propel market dynamics, ensuring a steady surge in demand for anthrax vaccines.
Region with highest CAGR:
Asia Pacific is projected to hold the highest CAGR over the forecast period. Government initiatives promoting vaccination, coupled with advancements in healthcare infrastructure, contribute to market expansion. Key players in the region are focusing on research and development to enhance vaccine efficacy. The growing emphasis on public health measures and preparedness against bioterrorism incidents further propels the demand for anthrax vaccines in the region.
Key players in the market
Some of the key players in Anthrax Vaccine market include AstraZeneca, BioNTech SE, Colondo Serum Company, Emergent Bio Solutions, Merck & Co., Inc, Moderna Inc., Pfizer Inc, Proton Biopharma Ltd, Sanofi, Seqirus, Serum Institute of India Pvt. Ltd and ICON plc.
Key Developments:
In October 2022, ICON plc was selected by the US Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) in the Department of Health and Human Services (HHS), to execute an anthrax vaccine clinical trial. The Anthrax vaccine AV7909 is currently under clinical trial evaluation.
In June 2022, Emergent BioSolutions Inc. was granted review acceptance of the Biologics License Application (BLA) for AV7909 (Anthrax Vaccine Adsorbed, Adjuvanted) from the US FDA. AV7909 is evaluated for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis in adults (age group 18 - 65). The Prescription Drug User Fee Act (PDUFA) goal date for a decision by the FDA is in April 2023.
Vaccine Types Covered:
• Live Attenuated Vaccine
• Cell Free PA Vaccine
• Other Vaccine Types
Types Covered:
• Subunit Vaccines
• Viral Vector Vaccines
• Other Types
Disease Indications Covered:
• Viral Disease
• Bacterial Vaccine
• Other Disease Indications
Age Groups Covered:
• Adult
• Pediatric
Applications Covered:
• Human Use
• Animal Use
• Other Applications
End Users Covered:
• Pharmacies
• Hospitals
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Anthrax Vaccine Market, By Vaccine Type
5.1 Introduction
5.2 Live Attenuated Vaccine
5.3 Cell Free PA Vaccine
5.3.1 Anthrax Vaccine Absorbed (AVA)
5.3.2 Anthrax Vaccine Precipitated (AVP)
5.4 Other Vaccine Types
6 Global Anthrax Vaccine Market, By Type
6.1 Introduction
6.2 Subunit Vaccines
6.2.1 Toxoid Vaccines
6.2.2 Conjugate Vaccines
6.2.3 Recombinant vaccines
6.3 Viral Vector Vaccines
6.4 Other Types
7 Global Anthrax Vaccine Market, By Disease Indication
7.1 Introduction
7.2 Viral Disease
7.2.1 Influenza
7.2.2 Hepatitis
7.2.3 Herpes Zoster
7.2.4 Rotavirus
7.2.5 Other Viral Diseases
7.3 Bacterial Vaccine
7.3.1 Pneumococcal Diseases
7.3.2 Meningococcal Diseases
7.3.3 Bacterial Vaccines
7.4 Other Disease Indications
8 Global Anthrax Vaccine Market, By Age Group
8.1 Introduction
8.2 Adult
8.3 Pediatric
9 Global Anthrax Vaccine Market, By Application
9.1 Introduction
9.2 Human Use
9.3 Animal Use
9.4 Other Applications
10 Global Anthrax Vaccine Market, By End User
10.1 Introduction
10.2 Pharmacies
10.3 Hospitals
10.4 Other End Users
11 Global Anthrax Vaccine Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa
12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies
13 Company Profiling
13.1 AstraZeneca
13.2 BioNTech SE
13.3 Colondo Serum Company
13.4 Emergent Bio Solutions
13.5 Merck & Co., Inc
13.6 Moderna Inc.
13.7 Pfizer Inc
13.8 Proton Biopharma Ltd
13.9 Sanofi
13.10 Seqirus
13.11 Serum Institute of India Pvt. Ltd
13.12 ICON plc
List of Tables
1 Global Anthrax Vaccine Market Outlook, By Region (2021-2030) ($MN)
2 Global Anthrax Vaccine Market Outlook, By Vaccine Type (2021-2030) ($MN)
3 Global Anthrax Vaccine Market Outlook, By Live Attenuated Vaccine (2021-2030) ($MN)
4 Global Anthrax Vaccine Market Outlook, By Cell Free PA Vaccine (2021-2030) ($MN)
5 Global Anthrax Vaccine Market Outlook, By Anthrax Vaccine Absorbed (AVA) (2021-2030) ($MN)
6 Global Anthrax Vaccine Market Outlook, By Anthrax Vaccine Precipitated (AVP) (2021-2030) ($MN)
7 Global Anthrax Vaccine Market Outlook, By Other Vaccine Types (2021-2030) ($MN)
8 Global Anthrax Vaccine Market Outlook, By Type (2021-2030) ($MN)
9 Global Anthrax Vaccine Market Outlook, By Subunit Vaccines (2021-2030) ($MN)
10 Global Anthrax Vaccine Market Outlook, By Toxoid Vaccines (2021-2030) ($MN)
11 Global Anthrax Vaccine Market Outlook, By Conjugate Vaccines (2021-2030) ($MN)
12 Global Anthrax Vaccine Market Outlook, By Recombinant vaccines (2021-2030) ($MN)
13 Global Anthrax Vaccine Market Outlook, By Viral Vector Vaccines (2021-2030) ($MN)
14 Global Anthrax Vaccine Market Outlook, By Other Types (2021-2030) ($MN)
15 Global Anthrax Vaccine Market Outlook, By Disease Indication (2021-2030) ($MN)
16 Global Anthrax Vaccine Market Outlook, By Viral Disease (2021-2030) ($MN)
17 Global Anthrax Vaccine Market Outlook, By Influenza (2021-2030) ($MN)
18 Global Anthrax Vaccine Market Outlook, By Hepatitis (2021-2030) ($MN)
19 Global Anthrax Vaccine Market Outlook, By Herpes Zoster (2021-2030) ($MN)
20 Global Anthrax Vaccine Market Outlook, By Rotavirus (2021-2030) ($MN)
21 Global Anthrax Vaccine Market Outlook, By Other Viral Diseases (2021-2030) ($MN)
22 Global Anthrax Vaccine Market Outlook, By Bacterial Vaccine (2021-2030) ($MN)
23 Global Anthrax Vaccine Market Outlook, By Pneumococcal Diseases (2021-2030) ($MN)
24 Global Anthrax Vaccine Market Outlook, By Meningococcal Diseases (2021-2030) ($MN)
25 Global Anthrax Vaccine Market Outlook, By Bacterial Vaccines (2021-2030) ($MN)
26 Global Anthrax Vaccine Market Outlook, By Other Disease Indications (2021-2030) ($MN)
27 Global Anthrax Vaccine Market Outlook, By Age Group (2021-2030) ($MN)
28 Global Anthrax Vaccine Market Outlook, By Adult (2021-2030) ($MN)
29 Global Anthrax Vaccine Market Outlook, By Pediatric (2021-2030) ($MN)
30 Global Anthrax Vaccine Market Outlook, By Application (2021-2030) ($MN)
31 Global Anthrax Vaccine Market Outlook, By Human Use (2021-2030) ($MN)
32 Global Anthrax Vaccine Market Outlook, By Animal Use (2021-2030) ($MN)
33 Global Anthrax Vaccine Market Outlook, By Other Applications (2021-2030) ($MN)
34 Global Anthrax Vaccine Market Outlook, By End User (2021-2030) ($MN)
35 Global Anthrax Vaccine Market Outlook, By Pharmacies (2021-2030) ($MN)
36 Global Anthrax Vaccine Market Outlook, By Hospitals (2021-2030) ($MN)
37 Global Anthrax Vaccine Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
